Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization
Authors
Keywords
-
Journal
EYE
Volume 26, Issue 7, Pages 1004-1011
Publisher
Springer Nature
Online
2012-05-18
DOI
10.1038/eye.2012.97
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic factors for visual outcomes 2-years after intravitreal bevacizumab for myopic choroidal neovascularization
- (2011) H Nakanishi et al. EYE
- Macular detachment after successful intravitreal bevacizumab for myopic choroidal neovascularization
- (2011) Noriaki Shimada et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- DIFFERENT DOSING OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION BECAUSE OF PATHOLOGIC MYOPIA
- (2011) Taku Wakabayashi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- PHOTODYNAMIC THERAPY IN HIGHLY MYOPIC EYES WITH CHOROIDAL NEOVASCULARIZATION
- (2011) André M Coutinho et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- PREDICTIVE FACTORS FOR VISUAL OUTCOME TO INTRAVITREAL BEVACIZUMAB IN YOUNG CHINESE PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2011) Jane Zea-Chin Kuo et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- TWO-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN JAPANESE PATIENTS WITH PATHOLOGIC MYOPIA
- (2011) Kengo Hayashi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- PROGNOSTIC FACTORS FOR VISUAL OUTCOME AFTER INTRAVITREAL ANTI-VEGF INJECTION FOR NAIVE MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2011) Jong UK Yoon et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Choroidal Neovascularization in Pathologic Myopia: Intravitreal Ranibizumab Versus Bevacizumab—A Randomized Controlled Trial
- (2010) Magda Gharbiya et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome
- (2010) Jose M. Ruiz-Moreno et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Long-term Pattern of Progression of Myopic Maculopathy
- (2010) Kengo Hayashi et al. OPHTHALMOLOGY
- Ranibizumab for Choroidal Neovascularization Secondary to Causes Other Than Age-Related Macular Degeneration: A Phase I Clinical Trial
- (2010) Jeffrey S. Heier et al. OPHTHALMOLOGY
- INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION COMPLICATING PATHOLOGIC MYOPIA
- (2010) FRANCK LALLOUM et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- MICROPERIMETRIC RETINAL CHANGES IN MYOPIC CHOROIDAL NEOVASCULARIZATION TREATED WITH INTRAVITREAL RANIBIZUMAB
- (2010) MONICA VARANO et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INTRAVITREAL ANTI-VEGF VERSUS PHOTODYNAMIC THERAPY WITH VERTEPORFIN FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2010) JONG UK YOON et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- MACULAR FUNCTIONAL CHANGES EVALUATED WITH MP-1 MICROPERIMETRY AFTER INTRAVITREAL BEVACIZUMAB FOR SUBFOVEAL MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2010) ANDREA SCUPOLA et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2010) RUFINO M. SILVA et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- TWELVE-MONTH OUTCOME AFTER ONE INTRAVITREAL INJECTION OF BEVACIZUMAB TO TREAT MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2010) Jose M Ruiz-Moreno et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Two-Year Visual Results for Older Asian Women Treated With Photodynamic Therapy or Bevacizumab for Myopic Choroidal Neovascularization
- (2009) Yasushi Ikuno et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisation
- (2009) T. Baba et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results
- (2009) J M Monés et al. EYE
- INTRAVITREAL RANIBIZUMAB FOR THE PRIMARY TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA
- (2009) TIMOTHY Y. Y. LAI et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- ANTI-VEGF DRUGS AS THE 2009 FIRST-LINE THERAPY FOR CHOROIDAL NEOVASCULARIZATION IN PATHOLOGIC MYOPIA
- (2009) SALOMON Y. COHEN RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study
- (2008) W-M Chan et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- CHANGES IN AQUEOUS VASCULAR ENDOTHELIAL GROWTH FACTOR AND PIGMENT EPITHELIAL-DERIVED FACTOR LEVELS FOLLOWING INTRAVITREAL BEVACIZUMAB INJECTIONS FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION OR PATHOLOGIC MYOPIA
- (2008) WAI-MAN CHAN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- SHORT-TERM EFFICACY AND SAFETY OF INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2008) RUFINO M. SILVA et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now